ScreenerHero

GHCGarofalo Health Care S.p.A.

BIT · IT · Healthcare · Medical Care Facilities · garofalohealthcare.com
5.620EUR-0.35%Mkt Cap: 541.27M $P/E: 23.50

Garofalo Health Care S.p.A., together with its subsidiaries, operates healthcare clinics in Italy. It operates through Hospital and Social/Dependency Care segments. The company offers high-complexity surgery, medium- and…

Industry Peers

Medical Care Facilities
Screen all
HCA
HCA Healthcare, Inc.
$95.21BUSDP/E 14.4
FRE
Fresenius SE & Co. KGaA
$28.53BUSDP/E 16.8
THC
Tenet Healthcare Corporation
$22.61BUSDP/E 10.9
FME
Fresenius Medical Care AG & Co. KGaA
$11.72BUSDP/E 12.1
FMS
Fresenius Medical Care AG & Co. KGaA
$12.47BUSDP/E 12.2
EHC
Encompass Health Corporation
$11.87BUSDP/E 20.1
DVA
DaVita Inc.
$11.16BUSDP/E 14.7
ENSG
The Ensign Group, Inc.
$10.46BUSDP/E 28.1
UHS
Universal Health Services, Inc. Class B
$10.45BUSDP/E 7.2
CHE
Chemed Corporation
$7.07BUSDP/E 27.2
PACS
PACS Group Inc.
$7.00BUSDP/E 25.9
LFST
LifeStance Health Group Inc. Common Stock
$4.76BUSDP/E 95.9
CON
Concentra Group Holdings Parent Inc. Common Stock
$4.46BUSDP/E 22.6
MCOV-B
Medicover AB (publ)
$3.50BUSDP/E 39.0
NHC
National HealthCare Corporation
$3.66BUSDP/E 26.2
OPCH
Option Care Health, Inc.
$3.55BUSDP/E 18.0
AVAH
Aveanna Healthcare Holdings Inc.
$2.87BUSDP/E 10.3
BKD
Brookdale Senior Living Inc.
$2.82BUSD
EMEIS
Emeis SA
$2.45BUSD
ACHC
Acadia Healthcare Company, Inc.
$2.59BUSD

Key Statistics

Company
Market Cap541.27M $
Enterprise Value787.57M $
Revenue (TTM)531.80M $
Gross Profit445.89M $
Net Income (TTM)25.44M $
Revenue/Share5.952 USD
Last Price5.620 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2.3K
CountryIT
SectorHealthcare
IndustryMedical Care Facilities
ISINIT0005345233
Valuation
P/E (Trailing)23.50
P/E (Forward)18.42
PEG—
EV/EBITDA9.88
EV/Revenue1.48
P/S1.01
P/B1.46
EPS (TTM)0.24
EPS (Forward)0.30
52W Range
4.34579% of range5.950
52W High5.950 EUR
52W Low4.345 EUR
Profitability
Gross Margin84.56%
Oper. Margin11.77%
EBITDA Margin14.99%
Profit Margin4.83%
ROE6.91%
ROA2.72%
Growth
Revenue Growth3.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF53.31M $
CapEx (TTM)36.45M $
FCF Margin6.55%
FCF Yield6.43%
Net Debt238.06M $
Net Debt/EBITDA2.99
Balance Sheet
Debt/Equity0.67
Current Ratio1.15
Quick Ratio1.04
Book Value/Sh3.837 EUR
Cash/Share0.1870 EUR
Dividends
Fwd Div Rate0.0900 EUR
Trail. Div Rate0.0930 EUR
Div. Yield1.66%
5Y Avg Yield—
Payout Ratio35.70%
Ex-Div DateMay 18, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)6.200 EUR
Upside (mean)+10.3%
Target Range6.200 EUR – 6.200 EUR
# Analysts1
Ownership
Shares Out.88.29M
Float24.88M
Insiders68.28%
Institutions10.48%
Technical
SMA 505.485 (+2.5%)
SMA 2005.311 (+5.8%)
Beta0.36
S&P 52W Chg19.18%
Avg Vol (30d)19.61K
Avg Vol (10d)9.86K
Technical Indicators
RSI (14)58.5
MACD0.0520
MACD Signal0.0594
MACD Hist.-0.0074
BB Upper5.724 EUR
BB Middle5.621 EUR
BB Lower5.518 EUR
BB Width3.65%
ATR (14)0.0716 EUR
Vol Ratio (20d)0.22x